Aysan Nozheh

Dr. Aysan Nozheh

orcid
Medical Doctor, Pathology Resident at Tehran University of M...

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Clinical Case Reports
Verified
Journal Article
Open access
SSSamaneh Salarvand
Samaneh Salarvand
Aysan NozhehAysan Nozheh
Aysan Nozheh
AAAlireza Abdollahi
Alireza Abdollahi
HSHassan Sohrabinia
Hassan Sohrabinia
This case report describes the management of a middle‐aged woman with abnormal uterine bleeding who developed Anti‐Jk and Anti‐M antibodies following multiple transfusions, illustrating the challenges in transfusion medicine. Despite initial negative antibody screening, repeat testing post‐transfusion revealed these clinically significant antibodies, demonstrating the dynamic nature of alloimmunization. The case highlights the importance of the MNS and Kidd blood group systems in transfusion reactions, particularly the risk of delayed hemolysis with anti‐Jk antibodies. Through serial antibody screening, advanced serological techniques, and close blood bank collaboration, antigen‐negative blood was successfully provided for her urgent surgical needs. This report emphasizes the critical need for vigilant antibody monitoring in multitransfused patients, the value of interdisciplinary coordination, and the importance of ongoing clinician education to improve transfusion safety in complex cases.

16 October 2024 in Cancer Reports
Verified
Journal Article
Open access
PEPouya Ebrahimi
Pouya Ebrahimi
MPMoloud Payab
Moloud Payab
ASAlireza Shariati
Alireza Shariati
NANeda Alipour
Neda Alipour
Aysan NozhehAysan Nozheh
Aysan Nozheh
MEMahbube Ebrahimpur
Mahbube Ebrahimpur
Background: Medullary thyroid cancer (MTC) is one of the rare neuroendocrine malignancies. This cancer is hereditary in approximately 20% of cases. Although lymph node (LN) metastasis is prevalent in MTC, distant metastasis is not commonly seen in these patients. The most common locations for metastasis are the lungs, liver, and bones. This study presents an extremely rare MTC metastasis to bone marrow (BM) and adrenal gland, which has not been reported before.Case: The patient was a 50‐year‐old man with a diagnosis of MTC and total thyroidectomy 2 months before his presentation. He came to the emergency department (ED) complaining of dyspnea, diffuse bone pain, nonbloody diarrhea, and abdominal cramps starting in the last month before. Initial treatment with intravenous fluid infusion and loperamide, due to the provisional diagnosis of infectious diarrhea, was ineffective. Further assessments revealed severe pancytopenia and a massive tumor above the left kidney. Bone marrow aspiration (BMA) and biopsy (BMB) led to the diagnosis of invasive metastasis of the MTC to the BM and the left adrenal gland. In the initial evaluations, his COVID‐19 test became positive, and despite all efforts, his condition deteriorated, and he died 5 days after admission due to respiratory distress.Conclusion: Most MTC cases present with thyroid nodules in the initial steps and are confined to the thyroid gland or the adjacent LNs. These cases are mostly cured by thyroidectomy and LN dissection. This neuroendocrine cancer infrequently becomes aggressive and involves other parts of the body. However, involving BM or adrenal gland has been scarcely reported. Due to ineffective red and white blood cell production, BM metastasis can cause pancytopenia and, consequently, pallor, fatigue, dyspnea, and susceptibility to infections. High calcitonin levels can also cause diarrhea. The initial diagnosis is mostly with neck ultrasound (US) and fine needle aspiration (FNA). Total thyroidectomy is the main therapeutic option for these patients. Calcitonin and carcinoembryonic antigen (CEA) are sensitive indicators of recurrence or remaining tumors, which might be helpful for the initial diagnosis and postoperation follow‐up. Although extremely rare, invasive metastasis of MTC might involve unusual body organs such as the BM or adrenal glands. In cases of unjustifiable pancytopenia or adrenal dysfunction in MTC‐positive patients, these possibilities should be considered and ruled out by some specific evaluations, such as bone marrow biopsy and contrast‐enhanced imaging.

25 February 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
AAAlireza Abdollahi
Alireza Abdollahi
SSSamaneh Salarvand
Samaneh Salarvand
FAFereshteh Ameli
Fereshteh Ameli
KYKimia Mozahheb Yousefi
Kimia Mozahheb Yousefi
Aysan NozhehAysan Nozheh
Aysan Nozheh
ZMZahra Modabber
Zahra Modabber
Gastric cancer (GC) remains a significant global health burden, characterized by high mortality rates, often due to late-stage diagnosis, resistance to conventional therapies, and metastatic dissemination. This narrative review synthesizes current preclinical and early clinical evidence on the diverse roles of curcumin, a natural polyphenolic compound derived from Curcuma longa (turmeric), in the context of gastric cancer. A comprehensive search of databases, including PubMed, Scopus, and Web of Science, was conducted, and approximately 140 studies were critically appraised to identify mechanistic insights and translational barriers. In this context, curcumin’s potential in preventing GC is explored, specifically regarding its potent anti-inflammatory and antioxidant properties, modulation of precancerous lesions, and anti-Helicobacter pylori activity. Furthermore, the review details curcumin’s mechanisms in treating established GC, including its ability to inhibit cancer cell proliferation, induce apoptosis (via pathways like PI3K/Akt/mTOR, NF-κB, STAT3), and exert anti-angiogenic effects. Crucially, its capacity to inhibit GC metastasis by reversing epithelial-mesenchymal transition (EMT), suppressing matrix metalloproteinases (MMPs), and modulating key signaling pathways involved in invasion and migration is highlighted. Additionally, curcumin’s role in overcoming chemoresistance is discussed. Despite its promising pleiotropic actions, the clinical translation of curcumin is significantly challenged by its poor bioavailability. Moreover, various strategies to enhance systemic absorption are addressed, emphasizing the critical need for well-designed clinical trials to validate its efficacy and safety in human GC patients. This review underscores curcumin’s potential as a valuable complementary or integrative therapeutic agent in gastric cancer management.

7 March 2026 in Journal of Medical Case Reports
Verified
Journal Article
Open access
NKNeda Karkeabadi
Neda Karkeabadi
RORamesh Omranipour
Ramesh Omranipour
Aysan NozhehAysan Nozheh
Aysan Nozheh
BFBorna Farazmand
Borna Farazmand
Saeid EsmaeilianSaeid Esmaeilian
Saeid Esmaeilian
Invasive lobular carcinoma of the breast exhibits distinct biological behavior and metastatic patterns compared with invasive ductal carcinoma, with a recognized tendency to involve unusual sites such as the gastrointestinal tract, peritoneum, and ovaries. These metastases are often clinically occult and may mimic primary gastrointestinal or gynecologic malignancies, leading to delayed diagnosis. We report the case of a 43-year-old Iranian woman with estrogen receptor-positive invasive lobular carcinoma who developed sequential multifocal metastases to the stomach, ovaries, peritoneum, rectum, and jejunum over a 9-year disease course. Initial biochemical progression, manifested by a rising serum cancer antigen 15-3 level, preceded overt radiologic or endoscopic findings. Gastric metastasis was confirmed by biopsy 6 years after primary treatment. Despite negative pelvic imaging, bilateral salpingo-oophorectomy revealed occult ovarian and peritoneal metastases. Subsequent rectal and small-bowel involvement were diagnosed following new gastrointestinal symptoms. The patient was managed with multiple lines of systemic therapy and remains under active treatment with disease confined to the abdominal cavity. This case highlights the insidious metastatic behavior of invasive lobular carcinoma and the limitations of conventional imaging in detecting gastrointestinal and ovarian involvement. Persistent or unexplained gastrointestinal symptoms and rising tumor markers in patients with a history of invasive lobular carcinoma should prompt consideration of metastatic disease and early histopathological evaluation.

30 September 2025 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
SRShahab Rafieian
Shahab Rafieian
HAHesam Amini
Hesam Amini
OROmid Rezaei
Omid Rezaei
Aysan NozhehAysan Nozheh
Aysan Nozheh
NYNiloofar Ayoobi Yazdi
Niloofar Ayoobi Yazdi
Background: Paragangliomas are neuroendocrine tumors that often present as solitary tumors. In this case report, we describe a patient with multiple head and neck paraganglioma associated with a mediastinal paraganglioma. Case presentation: The patient was a 46-year-old male with a history of surgical removal of a mass from the right side of the neck, who presented with dysphonia lasting two months, hoarseness, vague chest pain, and unilateral ptosis. CT angiography of the carotid arteries and thoracic aorta revealed multiple findings, including a well-defined enhancing mass measuring 33 × 39 mm in the aorto-pulmonary prevascular space, a grade I carotid body tumor on the left side of the neck, vagal paragangliomas on the right side of the neck, and a glomus jugulare tumor on the right side. These findings were collectively suggestive of multiple paragangliomas. The patient subsequently underwent surgical resection of the mediastinal tumor, and pathological examination confirmed the diagnosis of paraganglioma. Conclusion: This report details a rare case of paraganglioma with multiple head, neck, and mediastinal involvement, emphasizing the need for thorough evaluation and genetic assessment in atypical presentations.

4 October 2025 in Clinical Case Reports
Verified
Journal Article
Open access
ENElham Nazar
Elham Nazar
ATAida Tarighi
Aida Tarighi
EFElaheh Farmani
Elaheh Farmani
BVBehnoud Vesali
Behnoud Vesali
Aysan NozhehAysan Nozheh
Aysan Nozheh
Malignant germ cell tumors (GCTs) spreading to the central nervous system (CNS) are uncommon, particularly when it comes to spinal cord metastases, which are extremely rare. This report details a case involving a metastatic cervical spinal cord GCT in a patient who had previously been diagnosed with a primary malignant GCT of the right testicle 3 years earlier. The patient experienced progressive cervical pain, and imaging revealed a mass in the cervical spinal cord area. Histopathological analysis confirmed that the mass was a malignant GCT, indicating it was a metastatic spread from the original testicular tumor. This case underscores the rarity of spinal cord metastases resulting from GCTs and emphasizes the necessity of considering metastatic disease in patients with a history of GCTs when they present with neurological symptoms (as often the earliest and most common presenting features).